USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18153
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMirzac, Daniela
dc.contributor.authorChiosa, Vitalie
dc.contributor.authorGroppa, Stanislav
dc.date.accessioned2021-10-15T18:34:02Z
dc.date.available2021-10-15T18:34:02Z
dc.date.issued2021
dc.identifier.citationMIRZAC, Daniela, CHIOSA, Vitalie, GROPPA, Stanislav. Epileptic encephalopathy with CSWS: clinical case. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 52. ISSN 2537-6381.
dc.identifier.issn2537-6373
dc.identifier.issn2537-6381
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18153
dc.description.abstractBackground: Continuous spike-wave of sleep syndrome (CSWS), according to the ILAE, is characterized by epileptic seizures, neurocognitive deterioration, and specific EEG changes, mainly affects girls (40/60 ratio) between the age of 4 – 7 years. The aim of the study is the analysis of the clinical case of the CSWS in the context of scientific literature and prognosis evaluation, assuming correct application of the international protocol. Material and methods: Clinical case presentation. Results: A 10-year-old girl (18.09.2002) came in on 21.09.2012 with history of myoclonic seizures. Hypnogenic myoclonic jerks were described on the night video-EEG monitoring. The awake EEG pattern was unremarkable, but the sleep EEG pattern had characteristic signs of CSWS. The patient has no pathological history, the MRI was unremarkable. The therapy with clobazam 10 mg in the evening was initiated. Night video-EEG monitoring on 08.06.2013 was unremarkable. The patient is monitored for 9 years. On 27.07.2018, the dose was adjusted (5 mg). At the moment the patient is without neurocognitive decline, under treatment and continues the scheduled follow-up. From the epidemiological and symptomatic point of view, our case is homogeneous according to literature, located in the first standard deviation of the Gaussian curve. Considering the diagnosis, the recommended treatment achieved the goals: cessation of seizures, normalization of the EEG pattern, and the preservation of neurocognitive abilities. Conclusions: In the case of a non-structural etiology, early diagnosis and treatment initiation, provides favorable prognosis, with preservation of neurocognitive abilities and cessation of clinical and electrophysiological signs.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectCSWSen_US
dc.subjectvideo-EEG monitoringen_US
dc.subjectclobazamen_US
dc.titleEpileptic encephalopathy with CSWS: clinical caseen_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Epileptic_encephalopathy_with_CSWS.pdf75.1 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback